메뉴 건너뛰기




Volumn 22, Issue 11, 2012, Pages 3607-3611

Structure guided P1′ modifications of HEA derived β-secretase inhibitors for the treatment of Alzheimer's disease

Author keywords

secretase; A amyloid; Alzheimer's disease; Aspartyl protease; BACE inhibitors; Hydroxyethylene derivatives; Protease inhibitors

Indexed keywords

1 ETHOXYCYCLOPROPOXY TRIMETHYLSILANE; 2 HYDROXYL CHROMANS; 2 METHYLCYCLOBUTANONE; 2 METHYLPROPANE 1,3 DIOL; 3 HYDROXY CHROMAN; 3 HYDROXYCYCLOBUTANE; 3 METHYLCYCLOBUTANONE; 3,3 DIFLUORO CYCLOBUTANE; 8 AZACHROMAN AMINE; ALLYLCYCLOBUTANE; BETA SECRETASE; BETA SECRETASE INHIBITOR; CATHEPSIN D; CHROMAN DERIVATIVE; CYCLOBUTANONE DERIVATIVE; DITHIANE; SPIROCYCLOBUTYL COMPOUND; SULFINIMINE; UNCLASSIFIED DRUG; VINYL CYCLOPROPANE; VINYL PIVALATE;

EID: 84861196665     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2012.04.060     Document Type: Article
Times cited : (13)

References (22)
  • 15
    • 84873061544 scopus 로고    scopus 로고
    • PCT Int. Appl. WO2007061670
    • Zhong, W. et al. PCT Int. Appl. WO2007061670, 2007.
    • (2007)
    • Zhong, W.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.